`BIB_055`

Chapman PB, Hauschild A, Robert C, et al. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. NEJM 2011;364(26):2507–2516. PMID 21639808. BRIM-3 — first BRAF inhibitor OS benefit. [Tasks: L, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade: A
Tier: 2
Cited by tasks: L, 18
Identifiers: PMID:21639808

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_055/findings.md (research corpus). This page is a short context summary — not individualised medical advice.